Sign in and upgrade to a paid plan to export NAV history as CSV.
Sign in and upgrade to a paid plan to export board meetings as CSV.

Cian Healthcare Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 542678
₹24.00
▲ 0.47 (2.00%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
51/100
Moderate
Valuation
—/100
Data unavailable
Momentum
72/100
Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
474.2
Free Cash Flow
₹29 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
0.78
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

0 of 3 met
  • No Quality score is Strong (70 or more)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 1 met
  • Yes 1-year return beats the industry median

Value and momentum

3 of 4 met
  • Yes Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
2.0%
Low 24.0000 · High 24.0000
1W return
10.3%
Low 22.1800 · High 24.0000
1M return
107.1%
Low 12.1600 · High 24.0000
52W return
474.2%
Low 10.0200 · High 24.0000
Lifetime High ₹61.8000 (May 24, 2019)
Lifetime Low ₹4.1800 (Dec. 24, 2024)

Full price history and technicals →

EMA & SMA

Bullish6
Bearish0
5D
23.0
10D
21.5
20D
19.9
50D
19.9
100D
20.5
200D
20.9

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

24.00
Pivot
First resistance24.00
Second resistance24.00
Third resistance24.00
First support24.00
Second support24.00
Third support24.00
Day RSI66.8
Day MFI100.0
Day MACD1.28
Day MACD signal0.23

Beta

1M0.52
3M0.51
1Y0.51
3Y0.76

Price change analysis

↑ 107.1%
Over 1 Month
LowHigh
12.1624.00
↑ 474.2%
Over 3 Months
LowHigh
10.0224.00
↑ 474.2%
Over 6 Months
LowHigh
10.0224.00
↑ 474.2%
Over 1 Year
LowHigh
10.0224.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Ranks #None of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Mar 2026
  • Promoter95.00%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings increased from 27.10% to 95.00% in Mar 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
30 Dec 2025 RAJ BREEDERS AND HATCHERIES PRIVATE LIMITED Bulk Buy 150,000 5.3800 BSE
22 Dec 2025 NIKUNJ GHANSHYAM CHANDAK Bulk Buy 164,000 4.7700 BSE
22 Dec 2025 ANAND MOHAN . Bulk Buy 200,000 4.7200 BSE
22 Dec 2025 PRAVIN BRIJVALLABHA CHANDAK Bulk Buy 300,000 4.7200 BSE
22 Dec 2025 KANTA DEVI SAMDARIA Bulk Sell 354,000 4.7200 BSE
7 Nov 2025 PRADEEPCHOWDARYVEERAMACHINENI Bulk Buy 132,000 7.5000 BSE
4 Nov 2025 GUTTIKONDA VARA LAKSHMI Bulk Buy 170,000 7.3700 BSE
7 Oct 2025 GUTTIKONDA RAJASEKHAR Bulk Buy 512,000 4.9900 BSE
30 Jun 2025 SUMANTEKRIWAL Bulk Sell 2,000 4.1400 BSE
30 Jun 2025 KRISHNA MURARI TEKRIWAL Bulk Sell 132,000 4.1500 BSE

All bulk and block deals →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 AGM/EGM Cian Healthcare Ltd - 542678 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep 2026 AGM/EGM Cian Healthcare Ltd - 542678 - Shareholder Meeting / Postal Ballot-Outcome of AGM
5 Sep 2026 Company Update Cian Healthcare Ltd - 542678 - Disclosure Regarding Dispatch Of Letters To Those Shareholders Whose Email Addresses Are Not Registered With The Company/ Registrar And Transfer Agent And Depository Participants.
4 Sep 2026 AGM/EGM Cian Healthcare Ltd - 542678 - Notice Of The 23Rd (Twenty-Third) Annual General Meeting (''AGM'') Of The Company.
4 Sep 2026 Others Cian Healthcare Ltd - 542678 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Tight liquidity (Current Ratio 0.78)

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Cian Healthcare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.